NVIV - InVivo Therapeutics Holdings Corp.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD

Balance Sheet

All numbers in thousands
Period Ending12/31/201712/31/201612/31/2015
Current Assets
Cash And Cash Equivalents13,27121,82515,281
Short Term Investments-11,5775,274
Net Receivables---
Other Current Assets535451184
Total Current Assets13,80633,85320,739
Long Term Investments---
Property Plant and Equipment157510938
Intangible Assets---
Accumulated Amortization---
Other Assets82421115
Deferred Long Term Asset Charges---
Total Assets14,04534,78421,792
Current Liabilities
Accounts Payable2,6262,970895
Short/Current Long Term Debt4561,7372,302
Other Current Liabilities30141115
Total Current Liabilities3,1124,8483,312
Long Term Debt4008521,275
Other Liabilities56--
Deferred Long Term Liability Charges367135276
Minority Interest---
Negative Goodwill---
Total Liabilities3,9355,8354,863
Stockholders' Equity
Misc. Stocks Options Warrants---
Redeemable Preferred Stock---
Preferred Stock---
Common Stock111
Retained Earnings-183,907-157,007-133,569
Treasury Stock---
Capital Surplus194,016185,955150,497
Other Stockholder Equity---
Total Stockholder Equity10,11028,94916,929
Net Tangible Assets10,11028,94916,929